Stock Price
145.11
Daily Change
0.11 0.08%
Monthly
-20.67%
Yearly
-45.20%
Q1 Forecast
150.05

CSL reported $39.4B in Assets for its fiscal semester ending in June of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Arca Biopharma USD 509.25M 151.83M Sep/2025
aTyr Pharma USD 106.65M 5.12M Sep/2025
Bio Path USD 746K 1.45M Jun/2025
Brainstorm Cell Therapeutics USD 1.38M 1.19M Sep/2025
Cara Therapeutics USD 43.75M 4.8M Jun/2025
CSL USD 39.4B 957M Jun/2025
Curis USD 29.23M 10.09M Jun/2025
Esperion Therapeutics USD 364.02M 16.93M Sep/2025
Immunic USD 40.7M 20.72M Sep/2025
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Minerva Neurosciences USD 28.09M 2.33M Sep/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
TherapeuticsMD USD 40.13M 1.96M Jun/2024